The subcellular localization of photoreceptors is light dependent
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
And one theory is that theres this improvement in blood circulation to the scalp
PDA + GH secretagogue protocol: PDA: 500 mcg to 1 mg subcutaneous or oral, once daily (morning) CJC-1295/Ipamorelin: Standard dosing (typically 100 mcg each), before bed on empty stomach Duration: 8 to 12 weeks Note: The CJC-1295 dosage calculator helps determine individual dosing PDA + GHK-Cu GHK-Cu (copper peptide) is a naturally occurring tripeptide with potent regenerative properties
The agent is also able to inhibit MRAP1 and prevent the combination of GST and JNK, resulting in high JNK production that triggers tumor-cell apoptosis